Initiative Supports Cancer Patients in US Clinical Trials

06:12 EDT 19 Oct 2016 | PR Newswire

WASHINGTON, Oct. 19, 2016 /PRNewswire-USNewswire/ -- In response to Vice President Biden's call to action, Lazarex Cancer Foundation and ORIEN (Oncology Research Information Exchange Network) announce a new joint initiative addressing barriers to cancer clinical trial access by utilizing the IMPACT program (Improving Patient Access to Cancer Clinical Trials) to improve patient care and outcomes. "This initiative is the first step toward creating a sustainable transformation in the 'bench-to-bedside' process for clinical trial enrollment," said Lazarex President Dana Dornsife.

The IMPACT program brings together the significant resources of academic institutions, medical facilities and professionals, policy makers, industry, public health entities and community organizations nationwide, to collaboratively leverage their assets.  This combined effort will improve the overall enrollment, retention, and minority participation of patients in cancer trials within the ORIEN exchange for an additional 2,600 patients and their families. Each year, the anticipated joint program budget is expected to reach $7,500,000, and over $21,000,000 over a three year period, reimbursing the ancillary costs incurred by patients that would otherwise prevent them from participating. 

About the Lazarex Cancer Foundation

Lazarex Cancer Foundation is a not-for-profit organization focused on cancer care for advanced stage cancer patients and the medically underserved by providing assistance with costs for FDA trial participation, identification of clinical trial options, community outreach and education.


ORIEN is a unique research partnership among North America's top cancer centers including Moffitt Cancer Center in Tampa and the Ohio States University Comprehensive Cancer Center - Arthur G. James Cancer Hospital, and Richard J. Solove Research Institute in Columbus.

About Moonshot

During his 2016 State of the Union Address, President Obama called on Vice President Biden to lead a new, national Cancer Moonshot, focused on making a decade's worth of progress in preventing, diagnosing, and treating cancer in five years - ultimately striving to end cancer as we know it. A Presidential Memorandum on January 28, 2016 established the Cancer Moonshot Task Force.  More information on the Cancer Moonshot can be found here

Logo -

To view the original version on PR Newswire, visit:

SOURCE Lazarex Cancer Foundation


More From BioPortfolio on "Initiative Supports Cancer Patients in US Clinical Trials"

Quick Search

Relevant Topics

  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...

Cancer Disease
Cancer is not just one disease but many diseases. There are more than 100 different types of cancer. Most cancers are named for the organ or type of cell in which they start - for example, cancer that begins in the colon is called colon cancer; cancer th...